Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

NeoStem Raises $11 Million from Asian Investors

publication date: Apr 13, 2009

NeoStem, Inc. raised $11 million from a private placement with Asian investors. Much of the money will be spent to increase the company’s China operations. In November 2008, NeoStem gained control over a China regenerative medical therapy company, Shandong New Medicine Research Institute of Integrated Traditional and Western Medicine LLC. NeoStem says it will expand its medical tourism business, offering regenerative therapies that are not available in the West. More details...

Stock Symbol: (AMEX: NBS)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital